주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Friday, Aprill 19, 2024, 21:22
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
Samsung Biologics: 3Q22 Earnings Beat Despite Raised Market Consensus
Kim Tae-hee
2022.10.28 09:21
Celltrion at Odds with British Government over 'Penalizing Rebate'
Choi Moon-hee
2022.10.27 10:50
Samsung Biologics: To Benefit From FX Rates, Product Mix Improvement
Kim Tae-hee
2022.10.17 09:22
Finance
Bio Industry: GPM Improvement of 10%p Key for Competitiveness in US Biosimilar Market
Park Pyeong-kuk
2022.10.14 14:40
Finance
Pharmaceutical/bio: Limited Impact Expected from US Biotech Executive Order
Lee Dong-gun & Won Jae-hee
2022.09.22 09:08
Finance
Pharmaceutical/bio: Time for Momentum
Lee Dong-gun et al.
2022.09.07 09:01
Celltrion Healthcare: Prime Beneficiary of the Second Wave of Biosimilars
Kim Tae-hee
2022.08.31 09:22
Samsung Biologics: Inclusion of Samsung Bioepis to Boost Earnings
Kim Tae-hee
2022.08.31 09:18
Celltrion Healthcare: Conditions Met for a Virtuous Cycle Rally
Lee Dong-gun & Won Jae-hee
2022.08.18 11:55
Celltrion: Better Profitability, Increase in Remsima SC Market Share
Kim Tae-hee
2022.08.09 09:41
Celltrion: First Step toward a Virtuous Cycle Rally
Lee Dong-gun & Won Jae-hee
2022.08.09 09:35
Samsung Biologics: 2Q22 Review: Samsung Bioepis Fully Integrated
Park Pyeong-kuk
2022.08.01 09:00
처음
이전
이전
1
2
3
4
5
6
7
8
9
10
다음
다음
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기